Variant report
Variant | nsv946072 |
---|---|
Chromosome Location | chr1:92108421-92109716 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148337482 | chr1:92108421-92108422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201299292 | chr1:92108422-92108423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556541088 | chr1:92108425-92108426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs578228651 | chr1:92108430-92108431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111988310 | chr1:92108441-92108442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545249589 | chr1:92108512-92108513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117857370 | chr1:92108525-92108526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs199658447 | chr1:92108542-92108543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77233600 | chr1:92108547-92108548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560650675 | chr1:92108599-92108600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141463936 | chr1:92108618-92108619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200778949 | chr1:92108621-92108622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61746485 | chr1:92108622-92108623 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs116714084 | chr1:92108628-92108629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532467165 | chr1:92108667-92108668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536804898 | chr1:92108722-92108723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529914883 | chr1:92108736-92108737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547262460 | chr1:92108846-92108847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2493202 | chr1:92108899-92108900 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs145808123 | chr1:92108940-92108941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549453539 | chr1:92108958-92108959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2478176 | chr1:92108976-92108977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537842993 | chr1:92108986-92108987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199795352 | chr1:92108992-92108993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11808586 | chr1:92109056-92109057 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs184539919 | chr1:92109076-92109077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539284027 | chr1:92109086-92109087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563319978 | chr1:92109095-92109096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201470168 | chr1:92109102-92109103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114152586 | chr1:92109191-92109192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143076623 | chr1:92109194-92109195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs61746483 | chr1:92109198-92109199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571728983 | chr1:92109215-92109216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79658979 | chr1:92109223-92109224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560638502 | chr1:92109238-92109239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146163134 | chr1:92109244-92109245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17131513 | chr1:92109261-92109262 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs564931501 | chr1:92109293-92109294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532030006 | chr1:92109330-92109331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2493201 | chr1:92109336-92109337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs57723141 | chr1:92109364-92109365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs397953376 | chr1:92109365-92109366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547645556 | chr1:92109403-92109404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs17131777 | chr1:92109409-92109410 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs113929634 | chr1:92109416-92109417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547785787 | chr1:92109433-92109434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11811200 | chr1:92109443-92109444 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs548446601 | chr1:92109469-92109470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567740134 | chr1:92109491-92109492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11547721 | chr1:92109514-92109515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 16397240 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Prostate cancer | 19156837 | CNVD |
Autism | 17483303 | CNVD |
Malignant melanoma | 17260012 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:92097800-92109800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr1:92099200-92110600 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr1:92108400-92108600 | Enhancers | NHDF-Ad | bronchial |
4 | chr1:92108600-92109600 | Weak transcription | NHDF-Ad | bronchial |
5 | chr1:92109400-92110800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr1:92109400-92111400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr1:92109600-92110800 | Enhancers | NHDF-Ad | bronchial |
8 | chr1:92109600-92111400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr1:92109600-92119600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |